Completed PHASE4 INTERVENTIONAL 2-arm NCT05708690

Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery

Topical Application Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery

Sponsor: Indonesia University

Conditions Coronary Artery Disease Surgical Blood Loss Valvular Heart Disease

Interventions Tranexamic Acid 100 MG/ML normal saline

Updated 3 times since 2023 Last updated: Jan 31, 2023 Started: Oct 1, 2022 Primary completion: Dec 31, 2022 Completion: Jan 6, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05708690, this PHASE4 trial focuses on Coronary Artery Disease and Surgical Blood Loss and remains completed. Sponsored by Indonesia University, it has been updated 3 times since 2022, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Mar 2023 — Jul 2024 [monthly]

Completed PHASE4

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indonesia University

Data source: Indonesia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jakarta, Indonesia